Skip to main content

Table 1 Demographics and baseline characteristics

From: A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease

  POM-001 (N = 22)
Mean age (range), years 49.3 (28–58)
Gender, n (%)  
 Male 14 (64)
 Female 8 (36)
Mean weight (range), kg 89.0 (49.2–144.5)
Mean time since initial diagnosis (range), years 5.4 (0.106–25.12)
Mean % predicted MIP ± SD 40.3 ± 24.0
Mean % predicted MEP ± SD 35.5 ± 14.4
Mean MVV ± SD, L/min 68.9 ± 27.5
Mean % predicted FVC upright ± SD 60.9 ± 19.2
6MWT ± SD, meters 352.5 ± 151.1
  1. Abbreviations:
  2. 6MWT 6-min walk test, FVC forced vital capacity, MEP maximal expiratory pressure, MIP maximal inspiratory pressure, MVV maximum voluntary ventilation, SD standard deviation